Medicus Pharma Ltd.(MDCX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
MDCX Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Medicus Pharma Ltd. (MDCX), a Healthcare sector company. MDCX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of MDCX by reported 13-F value include Interchange Capital Partners, JANE STREET GROUP, XTX Topco Ltd, based on the most recent SEC filings. MDCX trades on the Nasdaq exchange and files with the SEC under CIK 1997296. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDCX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Medicus Pharma Ltd. directly from SEC EDGAR.
Net Income
Q2 2026
$-11.6M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-323.8% YoYOperating Income
-207.3% YoYEPS (Diluted)
-136.2% YoYTotal Assets
+78.2% YoYTotal Debt
Op. Cash Flow
-122.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Net Income | $-47.3M -323.8% | $-11.2M -109.9% | $-5.3M | — |
| Operating Income | $-34.4M -207.3% | $-11.2M -136.4% | $-4.7M | — |
| EPS (Diluted) | $-2.74 -136.2% | $-1.16 +24.2% | $-1.53 | — |
| Total Assets | $10.1M +78.2% | $5.6M +198.3% | $1.9M | — |
| Total Debt | $5.2M | $0.00 | — | — |
| Operating Cash Flow | $-22.8M -122.3% | $-10.2M -146.4% | $-4.2M | — |
Get alerted when MDCX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Medicus Pharma Ltd. including:
Top Institutional Holders of MDCX
Interchange Capital Partners, LLC
$718.4K1,586,871 shJANE STREET GROUP, LLC
$148.9K333,673 shXTX Topco Ltd
$108.6K243,362 shSterling Investment Advisors, Ltd.
$44.6K100,000 shARMISTICE CAPITAL, LLC
$39.4K60,600 shCOMMONWEALTH EQUITY SERVICES, LLC
$23.5K52,643 shMay Hill Capital, LLC
$22.6K50,622 shAnson Funds Management LP
$18.9K42,400 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$14.0K31,462 shSTIFEL FINANCIAL CORP
$13.4K30,000 sh
| Fund | Value | Shares |
|---|---|---|
| Interchange Capital Partners, LLC | $718.4K | 1,586,871 |
| JANE STREET GROUP, LLC | $148.9K | 333,673 |
| XTX Topco Ltd | $108.6K | 243,362 |
| Sterling Investment Advisors, Ltd. | $44.6K | 100,000 |
| ARMISTICE CAPITAL, LLC | $39.4K | 60,600 |
| COMMONWEALTH EQUITY SERVICES, LLC | $23.5K | 52,643 |
| May Hill Capital, LLC | $22.6K | 50,622 |
| Anson Funds Management LP | $18.9K | 42,400 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.0K | 31,462 |
| STIFEL FINANCIAL CORP | $13.4K | 30,000 |
More Healthcare Companies
View all Healthcare →Put MDCX on your watchlist
Track score changes the day Medicus Pharma Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MDCX a good stock to buy?
13F Pro's AI-powered analysis of Medicus Pharma Ltd. (MDCX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MDCX are available on the MDCX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MDCX is classified as a small company.
Which hedge funds own MDCX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MDCX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Medicus Pharma Ltd.'s investment landscape.